China Biotech Services Holdings Limited
Symbol: 8037.HK
HKSE
0.305
HKDMarket price today
-2.3428
P/E Ratio
0.0000
PEG Ratio
293.79M
MRK Cap
- 0.03%
DIV Yield
China Biotech Services Holdings Limited (8037-HK) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 206.9 | 92.8 | 152.3 | ||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | -128.6 | 1.8 | ||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 39.2 | 768.5 | 117.6 | ||||||||||||||||||
balance-sheet.row.inventory | 0 | 9.3 | 18.7 | 4.7 | ||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 5.8 | 4.8 | 3.1 | ||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 261.2 | 884.8 | 277.8 | ||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 124.2 | 128.9 | 105.5 | ||||||||||||||||||
balance-sheet.row.goodwill | 0 | 107.2 | 110.1 | 120.6 | ||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 69.8 | 67.3 | 80.9 | ||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 177 | 177.4 | 201.5 | ||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 56.9 | 227.7 | 120.3 | ||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 57.6 | -227.7 | 0 | ||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | -14.6 | 279.5 | 1.8 | ||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 401.2 | 585.7 | 429 | ||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.total-assets | 0 | 662.4 | 1470.5 | 706.8 | ||||||||||||||||||
balance-sheet.row.account-payables | 0 | 5.8 | 206.4 | 16.1 | ||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 94.7 | 16.6 | 63.6 | ||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 3.7 | 242 | 85.2 | ||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 5.7 | 65.2 | 3.6 | ||||||||||||||||||
Deferred Revenue Non Current | 0 | -5.7 | 0 | -9.9 | ||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 58.6 | 325.2 | 23.7 | ||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 12.2 | 95.3 | 13.5 | ||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5.7 | 20.3 | 11.1 | ||||||||||||||||||
balance-sheet.row.total-liab | 0 | 171.6 | 644 | 240.9 | ||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||
balance-sheet.row.common-stock | 0 | 96.3 | 96.3 | 96.3 | ||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | -310.8 | -209.9 | -475.1 | ||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 186.5 | 225.6 | 283.5 | ||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 490.7 | 490.7 | 490.7 | ||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 462.8 | 602.7 | 395.4 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 662.4 | 1470.5 | 706.8 | ||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 28 | 223.8 | 70.5 | ||||||||||||||||||
balance-sheet.row.total-equity | 0 | 490.7 | 826.5 | 465.9 | ||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||
Total Investments | 0 | 56.9 | 99.2 | 122 | ||||||||||||||||||
balance-sheet.row.total-debt | 0 | 100.4 | 81.8 | 67.2 | ||||||||||||||||||
balance-sheet.row.net-debt | 0 | -106.5 | -11 | -83.4 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -95.4 | 862.8 | 180.7 | ||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 55.6 | 66.4 | 68.1 | ||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 381.7 | 0 | 7.8 | ||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 1.9 | 2 | 5.2 | ||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 494.8 | -433.3 | -225.5 | ||||||||||||||||||
cash-flows.row.account-receivables | 0 | 729.9 | -656.4 | -64.9 | ||||||||||||||||||
cash-flows.row.inventory | 0 | -2.2 | -14 | -2.4 | ||||||||||||||||||
cash-flows.row.account-payables | 0 | -232.9 | 237.1 | -158.3 | ||||||||||||||||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | -645.9 | -15.2 | 4.2 | ||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -62.9 | -69.8 | -12.2 | ||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 7.5 | -6.5 | 0.5 | ||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | -51.8 | -0.5 | ||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0.1 | 4.1 | ||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | -128.4 | 0 | ||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -55.4 | -256.3 | -8.1 | ||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -31.1 | -8.2 | -52.2 | ||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | ||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -3.6 | -3 | -4.3 | ||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -9.6 | 0 | 0 | ||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -156 | -270.8 | -210.1 | ||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -149.4 | -282 | -266.6 | ||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -2.2 | -2.3 | 0.2 | ||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | 114.1 | -57.8 | -234 | ||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 206.9 | 92.8 | 150.6 | ||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 92.8 | 150.6 | 384.5 | ||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 192.6 | 482.7 | 40.5 | ||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -62.9 | -69.8 | -12.2 | ||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 129.7 | 413 | 28.3 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 212 | 1851.5 | 623.8 | ||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 177.7 | 750.6 | 265.7 | ||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 34.3 | 1101 | 358 | ||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0.6 | -3.4 | 0.7 | ||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 158 | 251.5 | 168.8 | ||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 335.7 | 1002.1 | 434.5 | ||||||||||||||||||
income-statement-row.row.interest-income | 0 | 3.7 | 0.2 | 0 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 5.3 | 3.5 | 6.5 | ||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -10.7 | 11.1 | -8.8 | ||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0.6 | -3.4 | 0.7 | ||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -10.7 | 11.1 | -8.8 | ||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 5.3 | 3.5 | 6.5 | ||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 55.6 | 58.4 | 68.1 | ||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||
income-statement-row.row.operating-income | 0 | -123.7 | 851.7 | 189.4 | ||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | -134.3 | 862.8 | 180.7 | ||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | -1.3 | 157.3 | 48.1 | ||||||||||||||||||
income-statement-row.row.net-income | 0 | -95.4 | 705.6 | 132.6 |
Frequently Asked Question
What is China Biotech Services Holdings Limited (8037.HK) total assets?
China Biotech Services Holdings Limited (8037.HK) total assets is 662362000.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.100.
What is company free cash flow?
The free cash flow is 0.200.
What is enterprise net profit margin?
The net profit margin is -0.535.
What is firm total revenue?
The total revenue is -0.796.
What is China Biotech Services Holdings Limited (8037.HK) net profit (net income)?
The net profit (net income) is -95447000.000.
What is firm total debt?
The total debt is 100396000.000.
What is operating expences number?
The operating expences are 158009000.000.
What is company cash figure?
Enretprise cash is 0.000.